BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29890181)

  • 1. Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study.
    Huo MR; Xu YJ; Zhai SZ; Lv M; Wang Y; Cao LQ; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Zhao MF; Liu KY; Huang XJ; Chang YJ
    Hum Immunol; 2018 Sep; 79(9):672-677. PubMed ID: 29890181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidates.
    Cao LQ; Lv M; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Huang XJ; Chang YJ
    Sci Rep; 2020 Feb; 10(1):2367. PubMed ID: 32047235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
    Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
    Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors.
    Lv M; Zhai SZ; Wang Y; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Cheng YF; Yan CH; Mo XD; Liu KY; Chang YJ; Huang XJ; Zhao XY
    Bone Marrow Transplant; 2019 Aug; 54(8):1287-1294. PubMed ID: 30655602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
    Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
    Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
    Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive assessment of sensitizing events and anti-HLA antibody development in women awaiting kidney transplantation.
    Picascia A; Grimaldi V; Sabia C; Napoli C
    Transpl Immunol; 2016 May; 36():14-9. PubMed ID: 27013139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HLA antibody profile of Turkish patients with end-stage renal disease.
    Karahan GE; Seyhun Y; Oguz F; Kekik C; Onal E; Caliskan Y; Bakkaloglu H; Yazici H; Turkmen A; Aydin AE; Sever MS; Eldegez U; Carin MN
    Transplant Proc; 2009 Nov; 41(9):3651-4. PubMed ID: 19917361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.
    Ling M; Marfo K; Masiakos P; Aljanabi A; Lindower J; Glicklich D; de Boccardo G; Greenstein S; Chapochnick-Friedmann J; Kayler L; Kinkhabwala M; Akalin E
    Hum Immunol; 2012 Sep; 73(9):879-83. PubMed ID: 22841893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
    Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
    J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of antibodies to HLA according to different cut-off values of mean fluorescence intensity in haploidentical allograft candidates: A prospective study of 3805 subjects.
    Ma N; Guo JP; Zhao XY; Xu LP; Zhang XH; Wang Y; Mo XD; Zhang YY; Liu YR; Zhao XS; Cheng YF; Liu KY; Huang XJ; Chang YJ
    HLA; 2022 Oct; 100(4):312-324. PubMed ID: 35681275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodies.
    Yamamoto H; Uchida N; Matsuno N; Ota H; Kageyama K; Wada S; Kaji D; Nishida A; Ishiwata K; Takagi S; Tsuji M; Asano-Mori Y; Yamamoto G; Izutsu K; Masuoka K; Wake A; Yoneyama A; Makino S; Taniguchi S
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1634-40. PubMed ID: 24972251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of antibodies towards HLA Class I and Class II in Malaysian renal transplant candidates.
    Khairul-Fahmy N; Ismail J; Koay BT; Md-Zakariah MZ; Mansor S; Zulkifli N; Mat-Ali SF; Mohamed R; Mustafa N; Arip M
    BMC Nephrol; 2023 Feb; 24(1):42. PubMed ID: 36829106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Different Sensitization Events on HLA Alloimmunization in Kidney Transplantation Candidates.
    Lopes D; Barra T; Malheiro J; Tafulo S; Martins L; Almeida M; Pedroso S; Dias L; Castro Henriques A; Cabrita A
    Transplant Proc; 2015 May; 47(4):894-7. PubMed ID: 26036480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.